Everything you need to know about TMS for PTSD: Breaking Through Treatment Resistance — how it works, what it costs, and how to find a provider who actually knows what they're doing.
The TMS Patient Buyer's Guide
Free 22-page guide — questions to ask, red flags, and how to choose the right provider.
Post-traumatic stress disorder (PTSD) affects approximately 3.5% of American adults in any given year, with dramatically higher prevalence among military veterans, first responders, and survivors of assault or accidents. Characterized by intrusive memories, hypervigilance, avoidance, negative cognitions, and emotional dysregulation, PTSD can devastate personal relationships, occupational functioning, and quality of life. While first-line treatments — including trauma-focused psychotherapy and SSRIs — are effective for many patients, a significant proportion experience persistent symptoms despite multiple treatment trials. Transcranial magnetic stimulation, both in its standard and deep forms, is being investigated as a novel intervention for treatment-resistant PTSD.
What You’ll Learn
- How PTSD changes brain structure and function, particularly in the amygdala and prefrontal cortex
- The difference between standard TMS and deep TMS (H-coil) for PTSD treatment
- Why TMS is not yet FDA-cleared for PTSD
- What is known about VA availability of TMS
- What a typical TMS treatment course for PTSD involves day to day
The Neurobiology of PTSD
PTSD is not simply a psychological reaction to trauma — it is accompanied by measurable changes in brain structure and function. Neuroimaging research has identified several key abnormalities:
The amygdala is consistently hyperactive in PTSD, showing exaggerated responses to threat-related stimuli including trauma cues, neutral stimuli perceived as dangerous, and even mild stressors. This hyperactivity underlies the hypervigilance, exaggerated startle response, and emotional reactivity that characterize the disorder.
The hippocampus — critical for memory encoding and contextualization — is often reduced in volume in PTSD patients and shows impaired functioning. This may explain why trauma memories in PTSD feel so raw and unprocessed: the hippocampus fails to contextualize them as memories of past events rather than ongoing threats.
The medial prefrontal cortex (mPFC), particularly the ventromedial prefrontal cortex, is underactive in PTSD. This region normally inhibits amygdala activity through top-down regulation. When mPFC function is compromised, the prefrontal “brake” on fear responses fails, allowing the amygdala to drive symptoms unchecked.
The default mode network (DMN) is dysregulated in PTSD, contributing to intrusive re-experiencing and rumination. Abnormal DMN connectivity is thought to underlie the phenomenon of trauma flashbacks, in which patients feel as though the traumatic event is happening in the present moment.
Standard TMS for PTSD
Standard TMS for PTSD most commonly targets the right and/or left dorsolateral prefrontal cortex (dlPFC). Treatment protocols typically use:
- Low-frequency (1 Hz) right dlPFC TMS to reduce right-hemisphere hyperarousal and dampen amygdala activity
- High-frequency (10 Hz or higher) left dlPFC TMS to enhance prefrontal regulatory function
- Bilateral protocols combining both approaches
The rationale for right-sided inhibitory stimulation is to calm the hyperactive fear circuitry; the rationale for left-sided excitatory stimulation is to strengthen the prefrontal cortex’s capacity to regulate the amygdala.
Deep TMS for PTSD
Deep TMS using the H-coil is a deeper-reaching coil design being studied for PTSD. Unlike standard figure-eight coils, which primarily stimulate surface brain regions, H-coils can reach deeper structures including the ACC, insula, and medial temporal regions — many of which are implicated in PTSD.
The BrainsWay deep TMS system has been studied in PTSD, including small trials of H-coil stimulation of the medial prefrontal cortex. Larger controlled trials are still needed.
What the Evidence Shows
The research on TMS for PTSD is early. Meta-analyses of small randomized and open-label trials have reported reductions in PTSD symptoms with rTMS compared with sham, but the trials are small and heterogeneous in targets and protocols. The 2017 VA/DoD guideline found insufficient evidence to recommend for or against rTMS for PTSD, and rTMS has been described as an intervention with emerging evidence by other guideline groups. Imaging studies suggest TMS may change activity in prefrontal and limbic circuits, but this has not been shown to translate into established clinical benefit.
FDA Status and VA Coverage
As of this writing, no TMS device is FDA-cleared for PTSD as a standalone indication. TMS devices are cleared for depression and several other conditions, and using TMS to treat PTSD is off-label. BrainsWay has publicly said it plans to seek FDA clearance for treating PTSD symptoms in patients with major depression, but a clearance has not been confirmed.
Some VA medical centers offer TMS, mainly for treatment-resistant depression, and veterans with PTSD and co-occurring depression may be able to access it. Availability and eligibility vary by facility, so ask your VA provider.
Because PTSD is an off-label use, insurers generally consider TMS for PTSD alone investigational. Coverage is more likely when a patient also has treatment-resistant major depression, which is a cleared indication. Check with your insurer and treatment team.
What Patients Can Expect
TMS courses for PTSD, which are off-label and not standardized, commonly mirror depression schedules: daily sessions (five days per week) for four to six weeks, each lasting roughly 20 to 37 minutes depending on the protocol. Treatment is administered in an outpatient setting without anesthesia.
For veterans and first responders with severe PTSD, the maintenance and booster session protocol is particularly important. Many clinicians recommend periodic “booster” sessions after the initial treatment course to sustain improvements, given that PTSD is often a chronic condition with a relapsing course.
A Comprehensive Approach
TMS should not be viewed as a standalone cure for PTSD. The most effective treatment programs integrate TMS with trauma-focused psychotherapy — particularly EMDR (eye movement desensitization and reprocessing) and prolonged exposure therapy — as well as psychiatric medication management when appropriate.
For veterans, active-duty service members, and civilian trauma survivors who have exhausted conventional treatment options, TMS is an investigational option that may be worth discussing with a clinician.
Frequently Asked Questions
Is TMS FDA-cleared for PTSD?
No. As of this writing, no TMS device is FDA-cleared for PTSD. TMS is cleared for depression, OCD, smoking cessation, and some other conditions, and its use for PTSD is off-label. BrainsWay has said it plans to seek clearance for PTSD symptoms in patients with depression.
Does the VA cover TMS for PTSD?
Some VA medical centers offer TMS, mainly for treatment-resistant depression. Availability and eligibility vary by facility, so ask your VA provider whether TMS is an option for you.
How is deep TMS different from standard TMS for PTSD?
Deep TMS uses H-coils that can reach deeper brain structures including the ACC, insula, and medial temporal regions — areas implicated in PTSD that standard figure-eight coils may not effectively reach. Whether this improves PTSD outcomes remains under study.
Ready to Explore Your TMS Options?
Browse verified TMS providers, read real reviews, and find the right treatment for your situation.
Related reading
- TMS for Veterans: Treating Depression, PTSD, and TBI in Military Personnel
- TMS for Multiple Sclerosis: Addressing Fatigue, Depression, and Cognitive Impairment
- What TMS Actually Feels Like: A Session-by-Session Guide
- How to Prepare for Your First TMS Session
- Take the TMS candidacy quiz
- Find a TMS clinic near you
